Ligand validation:6G9I

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6G9I_NAG_A_601	77%	83%	0.118	0.958	0.26	0.52	-	-	0	0	100%	0.9333
6G9I_NAG_A_602	33%	89%	0.211	0.892	0.22	0.42	-	-	0	0	100%	0.9333
6G9I_NAG_A_603	1%	40%	0.532	0.742	1.17	1.19	1	1	0	0	100%	0.9333
6G9I_NAG_A_604	1%	85%	0.592	0.768	0.31	0.42	-	-	0	0	100%	0.9333
6F6S_NAG_B_701	79%	82%	0.128	0.974	0.29	0.5	-	-	0	0	100%	0.9333
7SSR_NAG_A_601	75%	78%	0.112	0.945	0.34	0.54	-	-	0	0	100%	0.9333
7LYD_NAG_A_601	75%	72%	0.124	0.957	0.28	0.77	-	1	0	0	100%	0.9333
6F6N_NAG_A_501	72%	86%	0.133	0.958	0.21	0.51	-	-	0	0	100%	0.9333
5JQ3_NAG_A_601	63%	67%	0.13	0.924	0.27	0.97	-	1	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
4AKM_NAG_A_1379	100%	67%	0.029	0.994	0.54	0.73	-	-	0	0	100%	0.9333
3RIK_NAG_D_509	100%	8%	0.035	0.991	2.03	2.54	4	7	2	0	100%	0.9333
5VEM_NAG_B_509	100%	74%	0.003	0.957	0.46	0.56	-	-	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.